Literature DB >> 21181394

Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children.

D E Larson-Meyer1, B R Newcomer, E Ravussin, J Volaufova, B Bennett, S Chalew, W T Cefalu, M Sothern.   

Abstract

AIMS/HYPOTHESIS: We hypothesised that ectopic fat deposition is present in liver and skeletal muscle before puberty and that both are potentially important factors in the early pathogenesis of insulin resistance.
METHODS: Proton magnetic resonance spectroscopy was used to evaluate intramyocellular and intrahepatic lipids in 50 male and 42 female multi-ethnic, prepubertal (Tanner < 2) children (8.1 ± 0.8 years; 35.4 ± 10.7 kg; 27.9 ± 8.3% body fat; means ± SD). Intramyocellular lipid was measured in soleus muscle and intrahepatic lipid in the middle right lobe. Abdominal fat was measured by magnetic resonance imaging, body fat by dual energy X-ray absorptiometry, and insulin resistance using homeostatic model assessment.
RESULTS: Intrahepatic lipid ranged from 0.11% to 4.6% relative to the liver water signal (mean 0.79 ± 0.79%) whereas intramyocellular lipid ranged from 0.13% to 1.86% relative to the muscle water signal (mean 0.51 ± 0.28%). Intramyocellular and intrahepatic lipids were significantly correlated with total adiposity (r = 0.49 and 0.59), abdominal adiposity (r = 0.44 and 0.54), and each other (r = 0.39, p < 0.05, Spearman). Both intramyocellular and intrahepatic lipid were positively correlated with fasting insulin (r = 0.37 and 0.38 respectively) and insulin resistance (r = 0.37 and 0.37; p < 0.01). After adjustment for race and sex, the relations between ectopic fat and insulin resistance remained, whereas both disappeared when further adjusted for body fat or BMI z scores. CONCLUSIONS/INTERPRETATIONS: These results suggest that typical relations between body composition, ectopic fat and insulin resistance are present in children before puberty. Thus, interventions aimed at reducing adiposity have the potential to decrease ectopic fat accumulation, delay the onset of insulin resistance and decrease the risk for development of type 2 diabetes in children.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181394      PMCID: PMC3053439          DOI: 10.1007/s00125-010-2022-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  28 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects.

Authors:  S Jacob; J Machann; K Rett; K Brechtel; A Volk; W Renn; E Maerker; S Matthaei; F Schick; C D Claussen; H U Häring
Journal:  Diabetes       Date:  1999-05       Impact factor: 9.461

Review 3.  Banting lecture 1988. Role of insulin resistance in human disease.

Authors:  G M Reaven
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

4.  In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy.

Authors:  C Boesch; J Slotboom; H Hoppeler; R Kreis
Journal:  Magn Reson Med       Date:  1997-04       Impact factor: 4.668

5.  Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study.

Authors:  M Krssak; K Falk Petersen; A Dresner; L DiPietro; S M Vogel; D L Rothman; M Roden; G I Shulman
Journal:  Diabetologia       Date:  1999-01       Impact factor: 10.122

6.  Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity.

Authors:  S R Smith; J C Lovejoy; F Greenway; D Ryan; L deJonge; J de la Bretonne; J Volafova; G A Bray
Journal:  Metabolism       Date:  2001-04       Impact factor: 8.694

7.  Evaluation of HOMA and QUICKI as measures of insulin sensitivity in prepubertal children.

Authors:  Wayne S Cutfield; Craig A Jefferies; Wendy E Jackson; Elizabeth M Robinson; Paul L Hofman
Journal:  Pediatr Diabetes       Date:  2003-09       Impact factor: 4.866

Review 8.  Type 2 diabetes mellitus in children and youth: a new epidemic.

Authors:  Francine Ratner Kaufman
Journal:  J Pediatr Endocrinol Metab       Date:  2002-05       Impact factor: 1.634

9.  Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada.

Authors:  M Lambert; G Paradis; J O'Loughlin; E E Delvin; J A Hanley; E Levy
Journal:  Int J Obes Relat Metab Disord       Date:  2004-07

10.  Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents.

Authors:  G Perseghin; P Scifo; F De Cobelli; E Pagliato; A Battezzati; C Arcelloni; A Vanzulli; G Testolin; G Pozza; A Del Maschio; L Luzi
Journal:  Diabetes       Date:  1999-08       Impact factor: 9.461

View more
  24 in total

1.  The effects of muscle mass and muscle quality on cardio-metabolic risk in peripubertal girls: a longitudinal study from childhood to early adulthood.

Authors:  S Cheng; P Wiklund
Journal:  Int J Obes (Lond)       Date:  2017-10-30       Impact factor: 5.095

2.  [Correlation between ectopic fat accumulation and insulin sensitivity in obese individuals with different glucose tolerance levels].

Authors:  Shui-Qing Lai; Zhen-Zhen Hong; Hong-Mei Chen; Jin-Xin Lin; Jian Kuang; Yan-Bing Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-11-20

3.  Impaired insulin sensitivity and elevated ectopic fat in healthy obese vs. nonobese prepubertal children.

Authors:  Brian Bennett; D Enette Larson-Meyer; Eric Ravussin; Julia Volaufova; Arlette Soros; William T Cefalu; Stuart Chalew; Stewart Gordon; Steven R Smith; Bradley R Newcomer; Michael Goran; Melinda Sothern
Journal:  Obesity (Silver Spring)       Date:  2011-08-25       Impact factor: 5.002

4.  Obesity and type 2 diabetes: what can be unified and what needs to be individualized?

Authors:  Robert H Eckel; Steven E Kahn; Ele Ferrannini; Allison B Goldfine; David M Nathan; Michael W Schwartz; Robert J Smith; Steven R Smith
Journal:  J Clin Endocrinol Metab       Date:  2011-06       Impact factor: 5.958

5.  Intramyocellular lipid is associated with visceral adiposity, markers of insulin resistance, and cardiovascular risk in prepubertal children: the EPOCH study.

Authors:  David E Brumbaugh; Tessa L Crume; Kristen Nadeau; Ann Scherzinger; Dana Dabelea
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

6.  Lower body adipose tissue removal decreases glucose tolerance and insulin sensitivity in mice with exposure to high fat diet.

Authors:  K Cox-York; Y Wei; D Wang; M J Pagliassotti; M T Foster
Journal:  Adipocyte       Date:  2014-12-20       Impact factor: 4.534

7.  Prepubertal children exposed to concentrated disadvantage: An exploratory analysis of inflammation and metabolic dysfunction.

Authors:  Maura Kepper; Melinda Sothern; Jovanny Zabaleta; Eric Ravussin; Cruz Velasco-Gonzalez; Claudia Leonardi; Lauren Griffiths; Chi Park; John Estrada; Richard Scribner
Journal:  Obesity (Silver Spring)       Date:  2016-03-09       Impact factor: 5.002

8.  Inverse correlation of serum inflammatory markers with metabolic parameters in healthy, Black and White prepubertal youth.

Authors:  J Zabaleta; C Velasco-Gonzalez; J Estrada; E Ravussin; N Pelligrino; M C Mohler; E Larson-Meyer; A H Boulares; Y Powell-Young; B Bennett; K Happel; W Cefalu; R Scribner; T-S Tseng; M Sothern
Journal:  Int J Obes (Lond)       Date:  2013-11-26       Impact factor: 5.095

9.  Cardiometabolic Profile of Different Body Composition Phenotypes in Children.

Authors:  Yi Ying Ong; Jonathan Y Huang; Navin Michael; Suresh Anand Sadananthan; Wen Lun Yuan; Ling-Wei Chen; Neerja Karnani; S Sendhil Velan; Marielle V Fortier; Kok Hian Tan; Peter D Gluckman; Fabian Yap; Yap-Seng Chong; Keith M Godfrey; Mary F-F Chong; Shiao-Yng Chan; Yung Seng Lee; Mya-Thway Tint; Johan G Eriksson
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

10.  Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver.

Authors:  Rainer Lehmann; Holger Franken; Sascha Dammeier; Lars Rosenbaum; Konstantinos Kantartzis; Andreas Peter; Andreas Zell; Patrick Adam; Jia Li; Guowang Xu; Alfred Königsrainer; Jürgen Machann; Fritz Schick; Martin Hrabé de Angelis; Matthias Schwab; Harald Staiger; Erwin Schleicher; Amalia Gastaldelli; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan
Journal:  Diabetes Care       Date:  2013-03-20       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.